4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3,4:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[34:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders | Patent Publication Number 20230021717
US 20230021717 A1Patent NumberUS 11753419 B2
Application Number17757212
Filled DateDec 10, 2020
Priority DateDec 11, 2019
Publication DateJan 26, 2023
Original AssigneeIntracellular Therapies Inc.
Current AssigneeIntracellular Therapies Inc.
Inventor/ApplicantsKimberly Vanover
Robert E Davis
Peng Li
Peng LI
Robert E DAVIS
Robert E Davis
Peng Li
Peng LI
Robert E DAVIS
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.